OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Cancer is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Investigation of the gut microbiome, bile acid composition and host immunoinflammatory response in a model of azoxymethane-induced colon cancer at discrete timepoints	190
Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial	158
Advancing radiomics from contrast-enhanced mammography in breast cancer	149
Extruded small extracellular vesicles: splinters of circulating tumour cells may promote cancer metastasis?	140
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer	127
Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analy	125
The EXO1/Polη/Polι axis as a promising target for miR-3163-mediated attenuation of cancer stem-like cells in non-small cell lung carcinoma	122
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer	110
Years of life lost due to cancer in the United Kingdom from 1988 to 2017	110
Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC)	109
Correction: YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways	106
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition	106
Correction: Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation	106
Normal weight obesity, circulating biomarkers and risk of breast cancer: a prospective cohort study and meta-analysis	104
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer	99
Breast cancer risk prediction with a modified BOADICEA model in Danish women	97
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing	92
Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US	91
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer	90
Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis	89
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer	89
Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness	89
Metastasis-associated fibroblasts in peritoneal surface malignancies	84
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3	84
Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study	82

Proactive breast cancer risk assessment in primary care: a review based on the principles of screening	79
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity	78
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers	78
Neoplasm risk in individuals with neurofibromatosis 1 – a Danish nationwide cohort study with long-term follow-up	78
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)	77
Metabolic adaptations in prostate cancer	76
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities	75
DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma	74
Navigating therapeutic strategies: HPV classification in head and neck cancer	73
Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?	72
A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case–control studies	70
Genomic ALK alterations in primary and relapsed neuroblastoma	69
Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate	68
Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value	67
Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians	67
The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer	65
Identification of increased dedifferentiation along the Prom1+ cancer cells in Müllerian adenosarcoma with sarcomatous overgrowth	65
Circulating tumour DNA monitoring and early treatment for relapse: views from patients with early-stage melanoma	64
Hypoxia- and Postirradiation reoxygenation-induced HMHA1/ARHGAP45 expression contributes to cancer cell invasion in a HIF-dependent manner	64
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study	63
Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England	62
Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors	62
Optimizing adjuvant treatment strategies for non-pancreatic periampullary cancers	62
eIF3i facilitates NELFCD translation to promote metastasis via regulating EMT and invadopodia	61
EEF1A2 promotes HIF1A mediated breast cancer angiogenesis in normoxia and participates in a positive feedback loop with HIF1A in hypoxia	61
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy	61
The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination	58
The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England	57
Therapeutic impact of BET inhibitor BI 894999 treatment: backtranslation from the clinic	56
Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification	56
A systematic review of microbial markers for risk prediction of colorectal neoplasia	55
Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer	55
Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial	55